Analyst consensus rating
Dr. Reddy's Laboratories Analyst Rating: none
RDY is rated none by 5 analysts with a $13.49 target. As of 2026-08-29.
Direct answer
Dr. Reddy's Laboratories's consensus rating is none.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $13.49.
Forecast evidence checked August 29, 2026.
Get free Dr. Reddy's Laboratories email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $12.18
- Average price target
- $13.49
- High price target
- $15.78
- Low price target
- $11.40
- Low target gap
- -6.4%
- Target upside
- +10.7%
- High target gap
- +29.6%
- Target range width
- 36%
- Consensus rating
- none
- Analysts
- 5
- Evidence date
- August 29, 2026
- Valid through
- September 5, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Dr. Reddy's Laboratories?
Dr. Reddy's Laboratories has a verified none consensus. The same dataset has an average price target of $13.49.
How far are Dr. Reddy's Laboratories's low and high targets from the recorded price?
The low target implies -6.4%, while the high target implies +29.6%.
How many analysts are included in Dr. Reddy's Laboratories's consensus?
The verified consensus includes 5 analysts.
How is Dr. Reddy's Laboratories's target upside or downside calculated?
The average target of $13.49 is divided by the recorded price of $12.18, then one is subtracted to produce +10.7%. This does not guarantee a future return.
When was Dr. Reddy's Laboratories's analyst forecast verified?
The data was verified on 2026-08-29. The dataset is valid through 2026-09-05.